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Abstract
Early-onset torsion dystonia is a severe, life-long disease that leads to loss of motor control and involuntary muscle
contractions. While the molecular etiology of the disease is not fully understood, a mutation in an AAA+ ATPase, torsinA, has
been linked to disease onset. Previous work on torsinA has shown that it localizes to the endoplasmic reticulum, where
there is evidence that it plays roles in protein trafficking, and potentially also protein folding. Given the high level of
evolutionary conservation among proteins involved in these processes, the ability of human such proteins to function
effectively in yeast, as well as the previous successes achieved in examining other proteins involved in complex human
diseases in yeast, we hypothesized that Saccharomyces cerevisiae might represent a useful model system for studying
torsinA function and the effects of its mutants. Since torsinA is proposed to function in protein homeostasis, we tested cells
for their ability to respond to various stressors, using a fluorescent reporter to measure the unfolded protein response, as
well as their rate of protein secretion. TorsinA did not impact these processes, even after co-expression of its recently
identified interacting partner, printor. In light of these findings, we propose that yeast may lack an additional cofactor
necessary for torsinA function or proteins required for essential post-translational modifications of torsinA. Alternatively,
torsinA may not function in endoplasmic reticulum protein homeostasis. The strains and assays we describe may provide
useful tools for identifying and investigating these possibilities and are freely available.
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Introduction
A glutamic acid deletion (DE) in torsinA is associated with early-
onset torsion dystonia, a devastating autosomal dominant
neurofunctional disease that impacts patients as children or young
adults and has no cure [1]. The torsinA protein carries a signal
sequence in its N-terminus that localizes the protein to the
contiguous lumen of the endoplasmic reticulum (ER) and nuclear
membrane [2,3,4]. C-terminal to this is a hydrophobic region that
allows torsinA to interact with membranes [5]. The remainder of
the protein encompasses an AAA+ ATPase domain, which
includes the site of the dystonia-associated mutation [6].
While AAA+ ATPase domains have been ascribed diverse
functions, many are involved in protein remodeling [7]. Yeast
have AAA+ ATPases that participate in protein folding, such as
HSP104 [8], but none are homologs of torsinA. However, there is
precedent for successfully studying AAA+ ATPases in heterologous
environments, as HSP104 has been shown to function in neurons,
which lack an HSP104 homolog [9].
TorsinA acts in protein trafficking and the dystonia-associated
mutation in torsinA disrupts this process [10,11]. Due to the
homology between torsinA and the Hsp100 family, it was
hypothesized that torsinA may function as a chaperone. Indeed,
recent work has shown that torsinA can untangle protein
aggregates in vitro and rescue both nematodes and mouse
embryonic fibroblasts from ER stress [12,13]. However, work in
PC6.3 cells showed that while the ER stressor dithiothreitol (DTT)
induces post-translational modification of torsinA in rat PC6.3
cells, torsinA cannot rescue ER stress or protein aggregation of
polyglutamine in these cells [14]. This discrepancy may arise from
differences between cell lines. The latter paper was the only one to
use a neuronal cell line, which may be the most representative of
the cell type impacted by dystonia. TorsinA is present in Lewy
bodies (LB), the proteinaceous aggregates that are a hallmark of
Parkinson’s disease (PD) [15,16]. TorsinA is able to reduce the
aggregation of a principal component of LB, alpha-synuclein (a-
syn), in H4 neuroglioma cells, and lessen the neuronal death
caused by a-syn expression in nematodes [17,18]. This aspect of
torsinA biology is not understood, since torsinA is localized to the
ER [3] and LB and a-syn exist in the cytoplasm [16,17]. Hence,
while data suggest certain cellular functions for torsinA, the details
of this role in protein homeostasis is far from understood and it is
unclear how the disease-associated mutation of torsinA interferes
with its proposed chaperone function in the ER.
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Many studies have revealed the utility of modeling complex
biology in the yeast Saccharomyces cerevisiae. Yeast have an unrivaled
genetic toolbox for both hypothesis-based and unbiased high-
throughput analyses [19]. Furthermore, yeast have been vital in
understanding processes involved in protein homeostasis, includ-
ing the unfolded protein response (UPR) and the role of
chaperones [20,21]. More recently, yeast have been utilized to
model the cell biology of neurodegenerative diseases, including
polyglutamine (polyQ) diseases (e.g., Huntington’s disease) [22],
synucleinopathies (e.g., PD) [23], and Alzheimer’s disease
[24,25,26].
Studies of this nature concerning the cell-biological role of a-syn
have been particularly successful. a-Syn elicits toxicity when
expressed in yeast, as well as cellular phenotypes reminiscent of
those observed in PD patients [23]. From high-throughput screens,
our lab and others began to elucidate how a-syn expression alters
normal cellular functions. One such screen assayed the conse-
quences of overexpressing individual yeast genes on a-syn-induced
toxicity; this revealed conserved cellular processes perturbed by a-
syn expression in yeast and higher eukaryotes, including ER-to-
Golgi trafficking, and established a link between a-syn and PARK9,
a gene previously associated with PD by genetic analyses, but not
known to be functionally tied to a-syn [27,28,29]. A second yeast-
based screen discovered chemical compounds capable of rescuing
not only a-syn-induced toxicity in neurons, but also toxicity
triggered by the drug rotenone, which represents an independent
model for PD [30].
Motivated by the success of these prior yeast models, here we
attempt to investigate the cellular effects of torsinA expression in
Saccharomyces cerevisiae. Upon expression of torsinA in yeast, we find
that torsinA does not detectably impact protein folding and
secretion under the many conditions that we have tested. Although
we would not normally report negative results, we do so for several
reasons. First, due to the past success of modeling complex diseases
in yeast, we foresee others attempting similar studies and hope that
this work will serve as a starting point for their analyses. Secondly,
it is possible that our failure to detect significant changes upon
torsinA expression may be due to missing cofactors, improper
protein processing, or subcellular environmental differences
between yeast and higher eukaryotes. As these topics are
understood in greater detail, this model may come to serve as a
useful tool for the discovery of torsinA function and torsinA-
interacting partners. For these reasons, all plasmids created in this
study will be made freely available from Addgene.
Results
Expression of torsinA in the yeast ER requires a yeast ER
localization signal
TorsinA is a resident ER protein [2,3]. However, expression of
full-length torsinA in yeast, driven by a high-expression galactose-
inducible promoter, resulted in the formation of large cytoplasmic
aggregates (data not shown). Since we were interested in studying
the ability of torsinA to act specifically in the ER, we wished to
localize the protein to this cellular compartment. To accomplish
this, we replaced the endogenous ER localization sequence of
torsinA [4] with the localization sequence of the yeast ER-resident
protein, Kar2p (Figure 1A) [31]. Importantly, in this construct,
only the portion of torsinA that has been shown previously to be
cleaved following ER localization was replaced [3,5], leaving all
functional domains of the final protein intact. This caused torsinA
to localize to the ER, as visualized by C-terminal green fluorescent
protein (GFP) tagging of torsinA (Figure 1B). Even in the ER, the
protein still aggregated significantly when expressed from the
galactose-inducible promoter (data not shown). Therefore, the
expression level of torsinA was decreased by using the MET25
promoter. For all experiments other than microscopy, the GFP tag
was replaced with an HDEL (ER retention) motif to ensure that
any torsinA mistakenly trafficked to the Golgi apparatus would be
returned to the ER [32].
While the data presented below exclusively utilize this form of
torsinA, in which the endogenous localization sequence was
replaced with that from KAR2, pilot studies were performed using
two other fusion constructs. The first attached the KAR2
localization sequence to full-length torsinA and the second utilized
torsinA lacking both the endogenous signal sequence and
hydrophobic domain. Both of these forms of the protein elicited
similar results to those outlined below (data not shown).
Multiple isoforms of torsinA were used in these analyses
(Figure 1A). TorsinADE, the mutation associated with early-onset
torsion dystonia, lacks a glutamic acid at position 302 or 303 [6]. It
was hypothesized that this form of the protein may lose torsinA-
associated activity, as it has previously been shown that torsinADE
acts by a dominant-negative mechanism [10]. Furthermore, the
ATPase activity of torsinA is required for its chaperone function
[13]. Therefore, control constructs were created by inserting two
previously characterized mutations in the AAA+ domain into both
torsinA and torsinADE - K108A or E171Q, which inactivate ATP
binding and hydrolysis, respectively [33].
KAR2-tagged torsinA displayed predominantly ER-localized,
non-aggregated expression, suggesting the signal sequence was
sufficient for relocalization (Figure 1B) [34]. Some cytoplasmic foci
were still observed and low-level GFP was also seen in the vacuole
(arrowhead points to one example), suggesting that some of the
protein was being degraded (Figure 1B). We performed a spotting
assay to assess the impact of torsinA expression on the yeast
growth rate. None of the forms of torsinA examined impaired or
accelerated the rate of growth, suggesting that torsinA expression
did not significantly perturb any yeast cellular processes essential
for growth (Figure 1C). Importantly, torsinADE did not diminish
the growth rate of yeast, suggesting that the mutation does not act
by a dominant, gain of function mechanism to impede cell viability
in our model.
Expression of torsinA in yeast does not allow for
recapitulation of its roles in protein homeostasis and
trafficking
To test if torsinA could function as a chaperone, yeast strains
were assayed for ability to overcome protein folding perturbations
in the presence of wild type (WT) and mutant torsinA. To monitor
the onset of the UPR, we utilized a previously described reporter
that consists of GFP driven by four copies of the promoter from a
UPR-responsive gene (UPRE), thus allowing dose-dependent
monitoring of an upregulation in the UPR [35,36]. Each torsinA
construct elicited a slight, yet significant, basal increase in the UPR
in yeast, as compared to an empty vector (Figure 2A), likely due to
the expression of extra protein molecules in the ER. This was not
torsinA-specific, since the reporter gene luciferase, when expressed
in this manner, elicited the same response (data not shown). For
this reason, we assayed the ability of WT torsinA to modulate the
UPR in comparison to mutant forms of the protein, hypothesizing
that any biologically meaningful effects of torsinA expression
should be attenuated by the disease-associated mutation and/or
the mutations that inactivate ATP binding. None of the torsinA
isoforms elicited an UPR that was significantly different from the
others, suggesting that the rise in UPR was not due to mutant
torsinA dysfunction (Figure 2A).
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This assay was used to study the ability of torsinA to impinge
upon the UPR induced by oxidative protein damage in yeast by
treating torsinA-expressing cells with DTT. DTT causes oxidative
ER stress by inhibiting disulfide bond formation, thus eliciting the
UPR [36]. Recent work has suggested that a C. elegans homolog of
torsinA, ooc-5, can act as a sensor of intracellular oxidation, as it
contains a disulfide bond important for ATP/ADP binding [37].
DTT triggered the UPR in our strains; however, none of the
torsinA isoforms tested lowered the levels of DTT-induced UPR
(Figure 2A). To ensure that our reporter system was sensitive to the
functions of proteins known to reduce oxidative protein damage,
we expressed the yeast protein, ero1p. This protein is an oxidase
that is necessary for oxidative protein folding and can reduce levels
of UPR upon stress [36,38]. Indeed, we observed that it
significantly reduced the level of DTT-induced UPR (Figure 2A).
As a second assay to gauge the ability of torsinA to reduce
cellular stress associated with oxidative damage in yeast, torsinA
was expressed in a strain containing the ero1-1 mutation, resulting
in a temperature-sensitive ero1p that limits growth at 37uC [38].
Neither torsinA nor torsinADE impacted growth of ero1-1 at this
restrictive temperature (Figure 2B).
Next, we asked if torsinA could reduce the levels of the UPR
induced by sources other than oxidative stress in yeast. A
constitutively unfolded mutant form of carboxypeptidase Y
(CPY*) is an ER-associated degradation (ERAD) substrate that
can elicit the UPR [39]. Coexpression of any form of torsinA with
CPY* had no significant effect on the level of the UPR observed
(Figure 2A). Additionally, pilot studies were performed to test the
ability of torsinA to reduce the UPR elicited by tunicamycin, a
glycoprotein synthesis inhibitor; however, no significant differences
were observed (data not shown).
Multiple studies have documented that torsinA plays a role in
vesicular trafficking [10,11,40]. Similar to the chaperone system
that oversees protein folding, secretion is a highly conserved
pathway with many proteins displaying extensive homology
between yeast and higher organisms [41]. Therefore, we
investigated whether torsinA expression altered protein trafficking
in yeast. To do so, we utilized a previously established assay for
secretion that monitors trafficking of the endogenous yeast protein
invertase to the plasma membrane, where it cleaves sucrose,
resulting in a local pH change [42]. This change can then be
monitored using the pH-sensitive dye bromocresol purple (BCP).
Figure 1. TorsinA can be expressed in the endoplasmic reticulum of yeast. (A) Diagram of constructs created for this work (upper panel)
and summary of the different forms of torsinA used in these experiments (lower panel). TorsinA was localized to the endoplasmic reticulum (ER) using
the signal sequence of the endogenous yeast protein KAR2 and an HDEL sequence. (B) Microscopy of yeast strains used. TorsinA was localized to the
contiguous lumen of the nuclear envelope and ER. Some signal was also seen in the vacuole (arrow head), suggesting a portion of the protein was
degraded. A representative frame is shown for each strain. Scale bar = 2 mM. (C) Growth of torsinA-expressing yeast on plates. Each row is a 5-fold
dilution of the previous row. Expression of wild type (WT) or mutant torsinA did not impact the growth rate. Uninduced plates included 1 mM
methionine and induced plates lacked methionine.
doi:10.1371/journal.pone.0022744.g001
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Upon spotting torsinA-expressing strains onto BCP/sucrose plates,
no change was observed in the diameter of the halo that resulted
from this pH change, suggesting that secretion was not impacted
by any of the torsinA forms (Figure 2C).
It has also been suggested that torsinA can prevent the
progression of aggregate-associated neurodegeneration in models
of synucleinopathies and polyQ disorders [17,18]. Using the
previously described yeast model of a-syn-induced toxicity [23],
we asked whether concomitant expression of torsinA and a-syn
could rescue this phenotype; however, torsinA had no significant
impact on the rate of growth in conjunction with a-syn expression
(Figure 3).
Addition of the torsinA-interacting protein printor is not
sufficient to uncover the role of torsinA
The above-cited data suggested that torsinA expression in yeast
failed to affect any of the cellular processes in which this protein has
been shown to act in higher eukaryotic cells. We hypothesized that
this might be attributable to the fact that yeast lack certain essential
cofactor(s) that are required for torsinA function. Therefore, we
reassessed the ability of torsinA to function in the above-stated
pathways in the presence of the newly-discovered torsinA-interacting
protein, printor [4]. The association between torsinA and printor was
discovered through a yeast two-hybrid screen, suggesting that these
two proteins could, at a minimum, physically interact within a yeast
cell. Furthermore, this prior work demonstrated that printor
selectively binds torsinA lacking ATP, suggesting printor could act
as a cofactor of torsinA. TorsinA and printor specifically interact in
the ER, and not in the nuclear envelope. For this reason, printor was
localized to the ER using the Kar2 and HDEL localization
sequences, as described above for torsinA. Co-expression of WT
torsinA and printor in yeast failed to elicit differential cellular
phenotypes upon examination of CPY*- or DTT-induced UPR or
invertase trafficking (Figure 4A & B, respectively). TorsinADE and
printor elicited a small reduction of UPR induction upon co-
expression of CPY* (Figure 4A). While this reduction was statistically
significant, it is unlikely to be biologically relevant since torsinADE
was previously show to be inactive.
Figure 2. TorsinA does not impact the unfolded protein response or trafficking in yeast. (A) A construct containing GFP driven by a
unfolded protein response (UPR) sensitive promoter (UPRE-GFP) was used to monitor levels of the unfolded protein response (UPR) upon stress with
1.5 mM dithiothreitol (DTT) or mutant carboxypeptidase Y (CPY*). ERO1 served as a positive control. TorsinA is not able to reduce UPR levels caused
by either stressor. Statistical analysis was conducted in comparison to the vector control strain with a 1-tailed Student’s t-test. * = p,0.05,
#=p,0.005, & = p,0.001. N= 6 independent trials per sample. (B)Growth of ero1-1 in the presence and absence of torsinA at 37uC. Each row is a 5-
fold dilution of the previous row. TorsinA is not able to rescue the growth defect by the ero1-1 mutation. Uninduced plates included 1 mM
methionine and induced plates lacked methionine. (C) Trafficking of invertase, as monitored by halos produced by growth of torsinA-expressing
strains on plates containing bromocresol purple (BCP). TorsinA does not impact the rate of secretion.
doi:10.1371/journal.pone.0022744.g002
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Discussion
TorsinA has been proposed to function in two highly conserved
cellular processes: protein folding and protein trafficking. As such,
we hypothesized that torsinA expression in yeast would impact
these pathways. However, we failed to uncover a role for torsinA-
mediated control of protein folding and secretion in S. cerevisiae.
This observation was surprising because other protein folding and
remodeling factors, such as HSP90 [43] and HSP104 [9], are
readily analyzed when heterologously expressed in evolutionarily
divergent organisms. Moreover torsinA was shown to reduce
protein aggregation in vitro, and we hypothesized that these effects
would also extend to our yeast system [12].
However, our present findings can be easily reconciled with this
previous work. First, the above-cited in vitro study utilized torsinA
lacking both its signal sequence and its hydrophobic domain.
Secondly, the in vitro work, in contrast to previous in vivo work in
worms with the full-length torsinA protein [13], was unable to uncover
a functional difference between torsinA and torsinADE [12]. It is
possible that the same cofactors or post-translational modifications
that are necessary to explain the difference between the in vitro and in
vivo experiments also account for the inability of torsinA to be
biologically active in yeast. Alternatively, theremay be some difference
in the ER environment of the yeast cells as compared to higher
eukaryotic cell, which might prohibit its function or be redundant with
torsinA activity. Finally, we utilized both a signal sequence andHDEL
retention tag to express torsinA in the ER, but previous work [16,17]
suggests it may enter the cytosol, especially in times of proteolytic
stress. While the mechanism of this relocalization is not understood,
there are many examples of ER proteins being selectively transferred
to the cytoplasm when proteostasis be compromised, as occurs wtih
ER-associated protein degradation (ERAD) [44]. This would not
occur in our model due to the presence of the exogenous HDEL tag.
However, when we expressed torsinA directly in the cytosol, with or
without a-syn, torsinA had no effect on toxicity (data not shown).
There are a number of other possible explanations for these
disparities. While the majority of AAA+ ATPases act as protein
remoldeing factors, many have quite specific substrates [7], and it is
possible that yeast lack torsinA’s substrate(s). Furthermore, the UPR
may serve a broader range of functions in vertebrates than in yeast [45]
and torsinA may function in an aspect of UPR signaling not conserved
in yeast. Finally, as mentioned above, recent evidence suggests that
torsinA may not act in general protein homeostasis. Work in neuronal
lines has failed to recapitulate the role of torsinA in protein folding,
which, noteably, was only seen upon overexpression of torsinA in other
models [14]. Furthermore, torsinA has been knocked out in a variety of
model organisms, but none of these studies have reported a protein
homeostasis-related phenotype. This suggests that torsinA may serve a
different principal function, such as its role in maintaining nuclear
envelope structure, which has previously been shown to partially
explain the neuron-specific sensitivity of torsinA mutation [46].
As more is discovered about torsinA function and its interacting
proteins through neuronal culture or transgenic animals, the work
presented here may provide a platform for further investigation using
yeast. Furthermore, this yeast model might prove helpful in
discovering such cofactors, as it could be screened to identify human
genes that interact genetically with torsinA. For this reason, all of the
plasmids created for this project will be made freely available through
Addgene for distribution to others who are interested in testing these
hypotheses. While we failed to uncover a phenotype for torsinA
expression in yeast, we are optimistic that future work can improve
this model and make useful steps toward dissecting the function of
torsinA and the dysfunction associated with its mutant form.
Materials and Methods
Construction of plasmids
Except where noted, standard Gateway cloning methods were
used for cloning [47,48]. pDONR221 (Invitrogen) was used as the
donor plasmid and the pAG series of plasmids [49] were used as
destination vectors.
TorsinA and torsinADE were obtained as a generous donation from
Xandra Breakefield. Overlap extension PCR [50] was used to add the
KAR2 and HDEL localization sequences. These constructs were
expressed in pAG416Gal-ccdB or pAG416Gal-ccdB-GFP [49]. These
were then cut with XbaI andXhoI and subcloned into the same sites of
416-Met25. Site-directed mutagenesis was employed to create the
K108A and E171Q mutations using Pfu Turbo (Stratagene).
pRS313-CPY*-HA was a generous gift from Antony Cooper.
After sequencing, mutagenic PCR was used to create the same
mutation in CPY in pDONR221, which was then used in an LR
reaction to move to pAG413-Gal-ccdB [49].
pPW0533, the 304 4xUPRE-GFP reporter, was a generous
donation from Peter Walter. Following digestion in within the
TRP1 gene, it was transformed into W303 to make a stable strain
with an integrated copy.
Printor cDNA was purchased from Kazusa DNA Research
Institute (product ID ORK00224) [51]. Overlap extension PCR
[50] was used to add the Kar2 and HDEL localization sequences
and subclone into pDONR221.
Figure 3. TorsinA cannot rescue a-synuclein-induced toxicity in yeast. Assay showing the ability of yeast to grow in the presence or absence
of a-synuclein (a-syn) with and without torsinA. Each row is a 5-fold dilution of the previous row. TorsinA cannot rescue a-syn-induced toxicity.
doi:10.1371/journal.pone.0022744.g003
TorsinA Does Not Recapitulate Function in Yeast
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22744
Figure 4. Coexpression of torsinA and printor does not uncover a phenotype stemming from torsinA expression. (A) The UPR of the
indicated yeast strains was monitored by flow cytometry to detect expression from the UPRE-GFP construct upon stress with CPY* or 1.5 mM DTT.
Coexpression of printor does not allow WT torsinA to reduce UPR-related stress. A 1-tailed Student’s t-test was used to compare relative fluorescence
of torsinA strains to the vector control. * = p,0.01. N= 6 independent trials per each sample. (B) The impact of torsinA with and without printor on
trafficking of invertase. Cells were spotted on plates containing the pH sensitive dye, BCP. Simultaneous expression of torsinA and printor does not
impact the rate of secretion.
doi:10.1371/journal.pone.0022744.g004
TorsinA Does Not Recapitulate Function in Yeast
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Primers
Primers used in this work are summarized in Table 1.
Yeast strains and growth conditions
With the exception of CKY558 (ero1-1 containing strain; generous
gift from Chris Kaiser) [38], all experiments were done in the W303
genetic background. The standard lithium acetate transformation
protocol was used for all yeast transformations [52,53]. Minimal
media included 0.67% yeast nitrogen base without amino acids
(Fischer Scientific), supplemental amino acids (minus those needed as
selectable markers) (MP Biomedicals), and 2% sugar, with 2% agar
included in plates. All liquid growth was performed at 30uC with
aeration. Except where noted, growth on plates was performed at
30uC. For galactose induction (CPY* and a-syn), strains were grown
overnight in SRaff and diluted into SGal. For methionine induction
(torsinA and printor), cells were grown overnight in 1 mM
methionine overnight and diluted into media lacking methionine.
Materials
Dithiothreitol, tunicamycin, methionine, and bromocresol
purple (BCP) were purchased from Sigma.
Spotting assays
Cells were grown overnight in SRaff plus 1mM methionine.
Strains were diluted to OD600=1.0 and serially diluted five-fold for
six total repetitions before spotting on the appropriate agar plates.
UPRE induction assays
Cells were grown overnight in appropriate media. Strains were
diluted to OD600 = 0.1 in inducing media. DTT was used at the
indicated concentrations in order to induce a UPR. After 6 hours
of induction, cells were subjected to flow cytometry (Guava PCA-
96, Millipore).
Microscopy
Cells were grown to log phase in non-inducing media, then moved
to inducing media for 5 hours. Live cells were visualized by using a
Zeiss Axiovert 200 microscope. Z-stacks were taken and deconvoluted
using the nearest neighbor algorithm from the Axiovision software.
BCP trafficking assays
Cells were grown overnight in SD with 1 mM methionine
media. They were diluted to an OD600 = 1.0 and spotted onto
BCP plates containing (as measured in weight/volume) 0.67%
yeast nitrogen base without amino acids (Fischer Scientific),
supplemental amino acids (minus those needed as selectable
markers) (MP Biomedicals), 2% sugar, 2% agar, 0.0032% BCP,
and 0.56PBS. Plates were grown for 3 days at 30uC.
Statistical Analysis
All data are shown as mean 6 standard deviation. A 1-tailed
Student’s T –test was performed for all comparative statistical
analysis.
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